Journal
EXPERIMENTAL NEUROLOGY
Volume 282, Issue -, Pages 66-77Publisher
ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.expneurol.2016.05.023
Keywords
Magnetic Resonance Imaging; Spinal Cord Injury; Cell tracking; Hypotonic swelling; Mesenchymal Stem Cell
Categories
Funding
- EU [278850]
Ask authors/readers for more resources
In this study, murine Mesenchymal Stem Cells (MSCs) labeled with the clinically approved MRI agent Gadoteridol through a procedure based on the hypo-osmotic shock were successfully tracked in vivo in a murine model of Spinal Cord Injury (SCI). With respect to iso-osmotic incubations, the hypo-osmotic labeling significantly increased the Gd3+ cellular uptake, and enhanced both the longitudinal relaxivity (r(1)) of the intracellular Gadoteridol and the Signal to Noise Ratio (SNR) measured on cell pellets, without altering the biological and functional profile of cells. A substantial T-1 Contrast Enhancement after local transplantation of 3.0 x 10(5) labeled cells in SCI mice enabled to follow their migratory dynamics in vivo for about 10 days, and treated animals recovered from the motor impairment caused by the injury, indicating unaltered therapeutic efficacy. Finally, analytical and histological data corroborated the imaging results, highlighting the opportunity to perform a precise and reliable monitoring of the cell-based therapy. (C) 2016 Elsevier Inc. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available